Countouriotis Athena
President & CEO at Turning Point Therapeutics, Inc.
- Sold, on record
- $8.4M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 9, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Turning Point Therapeutics, Inc.President & CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Turning Point Therapeutics, Inc.UnusualFeb 11, 2021 2021
Sold 60,000 shares at $137.48 ($8.2M)
Countouriotis Athena, President & CEO
Sold 54.4% of holdings ($15.2M position)50,195 shares leftFirst sale on recordFiling
- 2 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedFeb 9, 2022 +363 days
Sold 2,971 shares at $36.30 ($108k)
Countouriotis Athena, President & CEO
Sold 5.8% of holdings ($1.8M position)47,930 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | Feb 11, 2022 | Turning Point Therapeutics, Inc. | President & CEO | Form 4 sale | 2,971 | $108k | 5.8% | Plan not stated | SEC |
| Feb 11, 2021 | Feb 11, 2021 | Turning Point Therapeutics, Inc. | President & CEO | Form 4 sale | 60,000 | $8.2M | 54.4% | Unusual | SEC |